(Q35097116)

6 August 2017

1 reference

title

Metolazone and its role in edema management (English)

1 reference

6 August 2017

1 reference

ChEBI release 2020-05-28

Domenic A Sica

1

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

published in

Congestive Heart Failure

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

100-105

1 reference

Severe Electrolyte Disturbances Associated With Metolazone and Furosemide

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Metolazone in treatment of severe refractory congestive cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Novel high-performance liquid chromatographic method using solid-phase on-line elution for determination of metolazone in plasma and whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Combination diuretic therapy in severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Diuretic resistance predicts mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Renal excretion of metolazone, a new diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Physiological Disposition of a New Diuretic, 14C-Metolazone, in Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Use of a New Diuretic Agent (Metolazone) in Patients With Edema and Ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Metolazone and spironolactone in cirrhosis and the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Furosemide pharmacokinetics in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

Refractory potassium repletion. A consequence of magnesium deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2003.01907.X

10.1111/J.1527-5299.2003.01907.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference